TPP feedback form

For detection technologies for medical abortion medicines tablets

9 March 2026
 | Technical document
TPP feedback form
Download (111 kB)

Overview

HRP (the UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction) and the World Health Organization (WHO) are developing a target product profile for a point-of-care or near-point-of-care technology to detect substandard or falsified mifepristone and misoprostol—two essential medicines used in medical abortion.  

We are now posting the draft target product profile for public consultation and invite you to share your feedback through this form.

 

 

 

 

WHO Team
Human Reproduction Special Programme (HRP), Sexual and Reproductive Health and Research (SRH)
Editors
HRP
Number of pages
1
Copyright
HRP